Pan fibroblast growth factor receptor inhibitor associated retinopathy.

Paris, Arianna; Bodaghi, Bahram; Touhami, Sara.

Afiliação

Paris A; Department of Ophthalmology, Pitié-Salpêtrière University Hospital, Sorbonne Université, Paris, France.
Bodaghi B; Clinic of Ophthalmology, Institute of Clinical Neurosciences of Southern Switzerland (INSI), Ente Ospedaliero Cantonale, Ospedale Regionale di Lugano, Lugano, Switzerland.
Touhami S; Department of Ophthalmology, Pitié-Salpêtrière University Hospital, Sorbonne Université, Paris, France.

Eur J Ophthalmol ; : 11206721231220334, 2023 Dec 12.

Article em En | MEDLINE | ID: mdl-38086757

Palavras-chave

Erdafitinib; FGFR inhibitor; fibroblast growth factor receptor inhibitor associated retinopathy; ocular toxicity; serous retinal detachment; side effects

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article